Drugs / iCM012
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06582485 | Sep 2025 → Dec 2026 expected | ischemic disease | iCoat Medical AB | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iCM012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06582485 ↗ |